Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls

Cabergoline compared to levodopa in the

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial

✍ Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos